Outcomes with transplanting kidneys offered through expedited allocation.


Journal

Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240

Informations de publication

Date de publication:
11 2023
Historique:
revised: 26 07 2023
received: 21 04 2023
accepted: 27 07 2023
medline: 13 11 2023
pubmed: 11 8 2023
entrez: 10 8 2023
Statut: ppublish

Résumé

Expedited out-of-sequence deceased donor kidney allocation is a strategy to avoid discards after early placement attempts have been unsuccessful. Our study aimed to assess outcomes and characteristics of these transplanted kidneys. KDPI matching was performed between expedited allocation (EA) and standard allocation (SA) deceased donor kidney transplants performed at our center. Between 2018 and 2021, there were 225 EA offers, and 189 (84%) were transplanted. EA recipients were older (p = .007) and had shorter dialysis vintage (p < .0001). EA kidneys were likely to be nationally allocated (p < .001), have AKI (p < .0001) and longer CIT (p < .0001). There were no differences in EA and SA time-zero kidney biopsies (ci, p = .07; ct, p = .89; cv, p = .95; ah, p = .79). EA kidneys had more DGF (p = .0006), but there were no differences in DGF duration (p = .83), hospital length of stay (p = .43), 1- and 2-year eGFR (p = .16, p = .99), patient (p = .34), or death-censored graft (p = .66) survival. During this study period, our center transplanted 189 kidneys through EA following local-regional declines. These kidneys often came from AKI donors and had more DGF but had similar outcomes to KDPI-matched SA kidneys. Although it has been suggested that EA has the potential to worsen transplant disparities, transplant center level decisions on organ acceptance contribute to these variations.

Identifiants

pubmed: 37563488
doi: 10.1111/ctr.15094
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15094

Informations de copyright

© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Cooper M, Formica R, Friedewald J, et al. Report of National Kidney Foundation Consensus Conference to decrease kidney discards. Clin Transplant. 2019;33(1):e13419.
Hart A, Lentine KL, Smith JM, et al. OPTN/SRTR 2019 Annual Data Report: kidney. Am J Transplant. 2021;21(Suppl 2):21-137.
Lentine KL, Smith JM, Hart A, et al. OPTN/SRTR 2020 Annual Data Report: kidney. Am J Transplant. 2022;22(Suppl 2):21-136.
Heilman RL, Mathur A, Smith ML, Kaplan B, Reddy KS. Increasing the use of kidneys from unconventional and high-risk deceased donors. Am J Transplant. 2016;16(11):3086-3092.
King KL, Husain SA, Perotte A, Adler JT, Schold JD, Mohan S. Deceased donor kidneys allocated out of sequence by organ procurement organizations. Am J Transplant. 2022;22(5):1372-1381.
Heilman RL, Smith ML, Kurian SM, et al. Transplanting kidneys from deceased donors with severe acute kidney injury. Am J Transplant. 2015;15(8):2143-2151.
Jadlowiec CC, Heilman RL, Smith ML, et al. Transplanting kidneys from donation after cardiac death donors with acute kidney injury. Am J Transplant. 2020;20(3):864-869.
Jadlowiec CC, Hanna WA, Ninan J, et al. Transplant outcomes using kidneys from high KDPI acute kidney injury donors. Clin Transplant. 2021;35(5):e14279.
Mohan S, et al. Characteristics and performance of unilateral kidney transplants from deceased donors. Clin J Am Soc Nephrol. 2018;13(1):118-127.
Mathur A, et al. Geographic variation in end-stage renal disease incidence and access to deceased donor kidney transplantation. Am J Transplant. 2010;10(4p2):1069-1080.
Jadlowiec CC, Frasco P, Macdonough E, et al. Association of DGF and early readmissions on outcomes following kidney transplantation. Transpl Int. 2022;35:10849. doi:10.3389/ti.2022.10849. Published 2022 Dec 23.
Calderon E, Chang YH, Chang JM, et al. Outcomes and health care utilization after early hospital dismissal in kidney transplantation: an analysis of 1001 consecutive cases. Ann Surg. 2022;275(2):e511-e519. doi:10.1097/SLA.0000000000003948
Jadlowiec CC, Hippen B, Gill J, et al. Current opinions on DGF management practices: a survey of the United States and Canada. Am J Transplant. 2023;23(3):387-392. doi:10.1111/ctr.14949
Dube GK, Brennan C, Husain SA, et al. Outcomes of kidney transplant from deceased donors with acute kidney injury and prolonged cold ischemia time - a retrospective cohort study. Transpl Int. 2019;32(6):646-657. doi:10.1111/tri.13406
Kayler LK, Magliocca J, Zendejas I, Srinivas TR, Schold JD. Impact of cold ischemia time on graft survival among ECD transplant recipients: a paired kidney analysis. Am J Transplant. 2011;11(12):2647-2656. doi:10.1111/j.1600-6143.2011.03741.x
Goh CC, Ladouceur M, Peters L, Desmond C, Tchervenkov J, Baran D. Lengthy cold ischemia time is a modifiable risk factor associated with low glomerular filtration rates in expanded criteria donor kidney transplant recipients. Transplant Proc. 2009;41(8):3290-3292. doi:10.1016/j.transproceed.2009.09.035
Husain SA, King KL, Pastan S, et al. Association between declined offers of deceased donor kidney allograft and outcomes in kidney transplant candidates. JAMA Netw Open. 2019;2(8):e1910312. published correction appears in JAMA Netw Open. 2019 Oct 2;2(10):e1914599. Published 2019 Aug 2.
Wang CJ, Wetmore JB, Wey A, Miller J, Snyder JJ, Israni AK. Impact of donor kidney biopsy on kidney yield and posttransplant outcomes. Am J Transplant. 2023;23(3):387-392. doi:10.1016/j.ajt.2022.11.020
Pre-implementation notice: minimum kidney donor criteria established for biopsies [Internet]. January 10, 2023. https://unos.org/news/pre-imp-min-kidney-donor-biopsy-criteria/
Dual and en bloc kidney allocation changes [Internet]. January 10, 2023. https://optn.transplant.hrsa.gov/news/dual-and-en-bloc-kidney-allocation-changes/
Ciancio G, Gaynor JJ, Sageshima J, et al. Favorable outcomes with machine perfusion and longer pump times in kidney transplantation: a single-center, observational study. Transplantation. 2010;90(8):882.

Auteurs

Caroline C Jadlowiec (CC)

Department of Surgery, Division of Transplant Surgery, Mayo Clinic, Phoenix, Arizona, USA.

Stephanie Y Ohara (SY)

Division of Surgery, Valleywise Health Medical Center, Creighton University, Phoenix, Arizona, USA.

Rachana Punukollu (R)

Department of Surgery, Division of Transplant Surgery, Mayo Clinic, Phoenix, Arizona, USA.

Josiah Wagler (J)

Department of Surgery, Division of Transplant Surgery, Mayo Clinic, Phoenix, Arizona, USA.

Brianna Ruch (B)

Department of Surgery, Division of Transplant Surgery, Mayo Clinic, Phoenix, Arizona, USA.

Kayla Kumm (K)

Department of Surgery, Division of Transplant Surgery, Mayo Clinic, Phoenix, Arizona, USA.

Pooja Budhiraja (P)

Division of Nephrology, Mayo Clinic, Phoenix, Arizona, USA.

Hay Me Me (HM)

Division of Nephrology, Mayo Clinic, Phoenix, Arizona, USA.

Amit K Mathur (AK)

Department of Surgery, Division of Transplant Surgery, Mayo Clinic, Phoenix, Arizona, USA.

Kunam S Reddy (KS)

Department of Surgery, Division of Transplant Surgery, Mayo Clinic, Phoenix, Arizona, USA.

Hasan Khamash (H)

Division of Nephrology, Mayo Clinic, Phoenix, Arizona, USA.

Raymond Heilman (R)

Division of Nephrology, Mayo Clinic, Phoenix, Arizona, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH